Disruption of the C/EBP?-miR-182 balance impairs granulocytic differentiation.

ABSTRACT: Transcription factor C/EBP? is a master regulator of myelopoiesis and its inactivation is associated with acute myeloid leukemia. Deregulation of C/EBP? by microRNAs during granulopoiesis or acute myeloid leukemia development has not been studied. Here we show that oncogenic miR-182 is a strong regulator of C/EBP?. Moreover, we identify a regulatory loop between C/EBP? and miR-182. While C/EBP? blocks miR-182 expression by direct promoter binding during myeloid differentiation, enforced expression of miR-182 reduces C/EBP? protein level and impairs granulopoiesis in vitro and in vivo. In addition, miR-182 expression is highly elevated particularly in acute myeloid leukemia patients with C-terminal CEBPA mutations, thereby depicting a mechanism by which C/EBP? blocks miR-182 expression. Furthermore, we present miR-182 expression as a prognostic marker in cytogenetically high-risk acute myeloid leukemia patients. Our data demonstrate the importance of a controlled balance between C/EBP? and miR-182 for the maintenance of healthy granulopoiesis.C/EBP? is a critical transcription factor involved in myelopoiesis and its inactivation is associated with acute myeloid leukemia (AML). Here the authors show a negative feedback loop between C/EBP? and miR-182 and identify this miRNA as a marker of high-risk AML.

SUBMITTER: Wurm AA 

PROVIDER: S-EPMC5491528 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature